<code id='EC3DA72FD3'></code><style id='EC3DA72FD3'></style>
    • <acronym id='EC3DA72FD3'></acronym>
      <center id='EC3DA72FD3'><center id='EC3DA72FD3'><tfoot id='EC3DA72FD3'></tfoot></center><abbr id='EC3DA72FD3'><dir id='EC3DA72FD3'><tfoot id='EC3DA72FD3'></tfoot><noframes id='EC3DA72FD3'>

    • <optgroup id='EC3DA72FD3'><strike id='EC3DA72FD3'><sup id='EC3DA72FD3'></sup></strike><code id='EC3DA72FD3'></code></optgroup>
        1. <b id='EC3DA72FD3'><label id='EC3DA72FD3'><select id='EC3DA72FD3'><dt id='EC3DA72FD3'><span id='EC3DA72FD3'></span></dt></select></label></b><u id='EC3DA72FD3'></u>
          <i id='EC3DA72FD3'><strike id='EC3DA72FD3'><tt id='EC3DA72FD3'><pre id='EC3DA72FD3'></pre></tt></strike></i>

          hotspot

          hotspot

          author:Wikipedia    Page View:3551
          Limor Appelbaum, radiation oncologist and a researcher working on the effort to predict pancreatic cancer for early detection, using AI analysis of vast amounts of electronic health records. -- health coverage from STAT
          Suzanne Kreiter/Globe staff

          Limor Appelbaum has seen too many patients whose first sign of a fatal illness came too late.

          Often it’s yellowed eyes from jaundice, caused by a cancerous tumor on the pancreas that has grown so large it presses against the bile duct system. By this point, little can be done. “All we can really offer them is something that can prolong life by a few months,” and comfort care, said Appelbaum, a staff scientist at Beth Israel Deaconess Medical Center.

          advertisement

          Only 11 percent of people diagnosed with pancreatic cancer are alive five years later.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more
          Readout Newsletter: Merck, J&J, and long Covid
          Readout Newsletter: Merck, J&J, and long Covid

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Beware the threat of staffing cuts at the CDC

          DavidGoldman/APThenation’shealthfacesadualthreat—oneanticipated,theother,self-inflicted.Covid-19hasn